11 | $CUZ News Article - Cousins Properties | whytestocks | 12/01/2023 2:31:13 PM |
10 | CUZ Stock Gapped up +0.02 $CUZ Last Price 9.25 | jim50 | 12/15/2015 8:54:30 PM |
9 | CUZ 9.98 Cousins Properties Inc $CUZ Hit a 52 | Emylers | 04/29/2015 3:23:28 PM |
8 | CUZ 10.08 Cousins Properties Inc $CUZ Hit a 52 | Emylers | 03/10/2015 11:21:36 AM |
7 | CUZ 10.19 Cousins Properties Inc $CUZ Hit a 52 | Emylers | 03/06/2015 11:04:22 AM |
6 | CUZ 10.65 Cousins Properties Inc $CUZ Hit a 52 | Emylers | 02/27/2015 11:05:12 AM |
5 | CUZ 10.63 Cousins Properties Inc $CUZ Hit a 52 | Emylers | 02/26/2015 11:04:14 AM |
4 | CUZ 11.47 Cousins Properties Inc $CUZ stock added | clayton | 12/05/2014 1:10:32 PM |
3 | Volume Alert - CUZ Stock 11.29 Cousins Properties | leahanne | 12/03/2014 12:21:34 PM |
2 | CUZ 12.43 Cousins Properties Inc $CUZ stock added | clayton | 11/28/2014 12:12:56 PM |
1 | CUZ Stock Charts Last: +0.06 Monday, March 3, | chartguy89 | 03/03/2014 8:30:24 PM |
Recent Articles
- NanoXplore Secures Long-Term Supply Agreement with CPChem
- Barfresh Food Group Expands Manufacturing with Arps Dairy Deal
- Masterbatch Market Growth Driven by Innovations and Sustainability
- Exciting Events Planned by Wave Life Sciences for Investors
- Northern Tool + Equipment Launches Exciting Student Challenge
- Welcoming Worley Monroe Advisors to LPL Financial's Network
- Lead Plaintiff Notice for Novo Nordisk Shareholders Announced
- Advent Technologies Secures Major Order from European Client
- Nexxen Strengthens Data Strategies with Eric Solomon's Leadership
- Legal Update for Replimune Group Shareholders: Your Rights Matter
- Grace Therapeutics Expands Patent Portfolio for GTx-104 Treatment
- Goosehead Insurance Partners with Nan & Company for Excellence
- Join the RxSight, Inc. Class Action for Investor Awareness
- iDEAL Semiconductor's New Manufacturing Partnership for Innovation
- Bollinger Innovations Implements Strategic Reverse Stock Split
- Understanding Lockheed Martin's Current Legal Challenges for Investors
- Rigetti and QphoX Join Forces for $5.8M Quantum Contract
- Important Notice for Fiserv, Inc. Shareholders on Legal Rights
- Innovative Weapons Detection: Xtract One Sets New Standards
- Innovative Breakthrough in Canine Cancer Treatments Using CAR-T
- Strategic Partnership Between IDCA and MDS UAE Enhances Services
- Exciting New Advertising Collaboration Announced by Adsposure
- Augment Me Unveils WotNow?! - AI Driven Productivity Tool
- 'Transforming Office Spaces: A Hotel-Like Approach Ahead'
- Explore the Thrills at Halloween House Freehold This Fall
- Life Sciences Virtual Investor Forum Offers On-Demand Access
- Discover the Top Password Managers to Use for Secure Online Living
- Parker-Hannifin Strengthens Position Through Curtis Acquisition
- Recognizing 25 Schools for Excellence in Mental Health Education
- Celebrating 50 Years of Flavor at Roscoe's Thank You LA Festival
- Viridi Partners with Schneider Electric for Sustainable Microgrids
- CommonArea Financial's Innovative Growth in Community Management
- How Grocers Can Thrive Without Losing Their Unique Identity
- Revolutionizing Investigations with Genetec Security Center SaaS
- Cultural Fusion: Luohu and Frankfurt Strengthen Ties
- Exciting Gift Showcases Unveiled for the Upcoming Season
- PDS Biotech Advances Cancer Treatment with Exciting Results
- New Insights on Colorectal Cancer Treatment for Older Adults
- Vestand's Strategic Acquisition to Strengthen Crypto Operations
- Waton Financial Limited Expands Presence in Digital Asset Market
- DeFi Development Corp. Launches Strategy for Global DAT Investments
- Primech Holdings Expands Reach in North America, Targets Growth
- Grace Therapeutics Expands Patent Portfolio for GTx-104
- Wave Life Sciences Dives into RNA Medicines at Virtual Event
- NanoXplore Enhances Industry Partnerships with New Contract
- Cannabix Technologies Showcases Innovative Breathalyzer Tech
- Craig Donnelly Takes the Helm as COO at Achieve Life Sciences
- Barfresh Food Group's Strategic Move to Enhance Growth Potential
- Clover Health's Dr. Ian Duncan Elected SOA President-Elect
- Oncotelic Therapeutics: Innovating Cancer Treatment Approaches